BNP Paribas Asset Management
ANAB icon

BNP Paribas Asset Management’s AnaptysBio ANAB Stock Holding History

BNP Paribas Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Sell
247
-10
-4% -$606 ﹤0.01% 2096
2026
Q1 		$14.3K Buy
257
+19
+8% +$1.02K ﹤0.01% 2123
2025
Q4 		$12K Sell
238
-34
-13% -$1.32K ﹤0.01% 2089
2025
Q3 		$8K Buy
272
+38
+16% +$872 ﹤0.01% 1681
2025
Q2 		$5K Buy
+234
New +$4.9K ﹤0.01% 1972

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BNP Paribas Asset Management's ANAB Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its AnaptysBio (ANAB) stake by 3.9% in Q2 2026, selling an estimated $606 and leaving 247 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

BNP Paribas Asset Management first reported a position in ANAB in Q2 2025 and has held it in 5 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • BNP Paribas Asset Management held 247 shares of AnaptysBio worth $16.7K as of Q2 2026.
  • BNP Paribas Asset Management sold 10 AnaptysBio shares in Q2 2026, an estimated $606.
  • AnaptysBio made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2096 holding.
  • BNP Paribas Asset Management first reported a position in AnaptysBio in Q2 2025 and has held it in 5 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.